血行力學之支持治療－輸液治療、升壓劑及強心劑

Hemodynamic Support: Fluid Therapy, Vasopressor and Inotropics

林少琳(Shoa-Lin Lin)

《重症醫學雜誌》 10卷1期 (2009/03) Pp. 21-26

https://doi.org/10.30035/TCCM.200903.0004

摘要

雖然救命技術有很大的進步，嚴重敗血症常併發較高的罹病率及死亡率，所以對嚴重的敗血症之處理仍然是一項挑戰。對敗血性休克之標準治療，包括抗生素、感染源控制，血行力學支持治療包括輸液、升壓劑及強心劑等之治療，使用這些治療方式如能注意早期目標導向之復甦治療，在隨機及控制組研究之經驗顯示，這種治療可對急診病患有改善死亡率之功效，此外，如能在6小時達到早期治療之目標，將可減少病患24小時之死亡率。
本文擬針對輸液治療、升壓及強心治療來介紹，其他之處置則不在本文範圍之內，而由其他作者來介紹。

關鍵字

輸液治療 ； 血行力學 ； 強心劑 ； 菌血症 ； 升壓劑

並列摘要

Despite spectacular advances in life-support technology, the management of patients with severe sepsis continues to be a significant health care challenge because of the associated major morbidity and high mortality. Standard therapy for patients with septic shock includes antibiotics, infection source control, and hemodynamic support with fluids and vasoactive medications. Early goal-directed resuscitation has been shown to improve survival for emergency department patients presenting with septic shock in a randomized, controlled study. Resuscitation directed toward the early goals for the initial 6-hr period of the resuscitation has been reported to be able to reduce 28-day mortality rate. This report focuses on the fluid therapy, vasopressor and inotropic supports. Other portions of management of patients with severe sepsis will be introduced by other specialists.

並列關鍵字

Fluid therapy ； Hemodynamic ； Inotropics ； Sepsis ； Vasopressor